Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | RARA | P10276 | 2/20 | 0.34 |
| ▸ | RARB | P10826 | 2/20 | 0.34 |
| ▸ | RARG | P13631 | 2/20 | 0.34 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.34 |
| ▸ | GOT1 | P17174 | 1/20 | 0.34 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.34 |
| ▸ | BLM | P54132 | 1/20 | 0.34 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | IKBKB | O14920 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 2/20 | 0.30 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29435382 | 1.00 | CNR2 (0.36) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL29435392 | 0.92 | KMT2A (0.34) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL22321076 | 0.92 | KMT2A (0.34) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL22321087 | 0.89 | KMT2A (0.35) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL29435380 | 0.89 | KMT2A (0.35) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL22321049 | 0.88 | CNR2 (0.38) | CNR2IKBKBKDM4E | |
| SCHEMBL29435388 | 0.88 | CNR2 (0.38) | CNR2IKBKBKDM4E | |
| SCHEMBL29435386 | 0.88 | CNR2 (0.38) | CNR2IKBKBKDM4E | |
| SCHEMBL22321073 | 0.88 | CNR2 (0.33) | CNR2KMT2AMEN1RARARARB | |
| SCHEMBL29435403 | 0.88 | CNR2 (0.33) | CNR2KMT2AMEN1RARARARB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11254763-B2 | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-02-22 | — | — | US | disclosed |
| US-11254763-B2 | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-02-22 | — | — | US | disclosed |
| WO-2020167821-A1 | TRANSITION METAL BIS(PHENOLATE) COMPLEXES AND THEIR USE AS CATALYSTS FOR OLEFIN POLYMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2020-08-20 | — | — | WO | disclosed |
| US-20200255553-A1 | Transition Metal Bis(Phenolate) Complexes and Their Use as Catalysts for Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
| US-20200255553-A1 | Transition Metal Bis(Phenolate) Complexes and Their Use as Catalysts for Olefin Polymerization | EXXONMOBIL CHEMICAL PATENTS INC. | 2020-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11254763-B2 | Transition metal bis(phenolate) complexes and their use as catalysts for olefin polymerization | CCNT1, CCNA1, CCNE2 | CNR2 2041/4885KMT2A 772/4885MEN1 2396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.